Literature DB >> 2758761

Increase in proteinuria and reduction in number of anionic sites on the glomerular basement membrane in rabbits by infusion of human nephrotic plasma in vivo.

A H Wilkinson1, C Gillespie, B Hartley, D G Williams.   

Abstract

1. Intraortic suprarenal infusion in vivo of New Zealand White rabbits with plasma from patients with the nephrotic syndrome reduced the number of anionic sites labelled by the cationic polymer polyethyleneimine in the lamina rara iterna to 14.0 +/- 2.7 per 1000 nm of lamina rara interna (mean +/- SD) compared with 18.7 +/- 2.1 (P less than 0.005) after infusion of plasma from normal subjects. 2. Proteinuria increased in all nine animals infused with nephrotic plasma and in two of seven infused with control plasma (P less than 0.01). The mean increase in proteinuria in the animals infused with nephrotic plasma was 246 mg/l (P less than 0.05), whereas in those infused with control plasma there was no increase. 3. We conclude that nephrotic plasma contains a factor(s) capable of neutralizing the charge of these anionic sites and concomitantly increasing proteinuria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2758761     DOI: 10.1042/cs0770043

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  3 in total

1.  Effect of lipoid nephrosis cytokine on glomerular sulfated compounds and albuminuria.

Authors:  E H Garin
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

2.  The effect of lymphocytes from renal transplant patients on glomerular basement membrane sulfate uptake.

Authors:  E H Garin; S E Self
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

3.  Novel mouse strains to study circulating permeability factor(s) in primary focal segmental glomerulosclerosis.

Authors:  Dirk den Braanker; Rutger Maas; Naomi Parr; Jeroen Deegens; Bart Smeets; Jack Wetzels; Johan van der Vlag; Tom Nijenhuis
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.